Cantor Fitzgerald Has Lowered Expectations for Enovix (NASDAQ:ENVX) Stock Price

Enovix (NASDAQ:ENVXGet Free Report) had its price target dropped by Cantor Fitzgerald from $30.00 to $25.00 in a report released on Thursday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 159.28% from the company’s previous close.

ENVX has been the subject of a number of other research reports. Wall Street Zen downgraded shares of Enovix from a “hold” rating to a “sell” rating in a research note on Saturday, September 6th. B. Riley reiterated a “buy” rating and set a $17.00 price target (up previously from $12.00) on shares of Enovix in a report on Thursday, July 10th. Canaccord Genuity Group lifted their target price on shares of Enovix from $20.00 to $22.00 and gave the stock a “buy” rating in a research report on Monday, August 4th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $12.00 price objective (up previously from $9.00) on shares of Enovix in a research report on Thursday, July 24th. Finally, Benchmark increased their price target on Enovix from $15.00 to $25.00 and gave the stock a “buy” rating in a research note on Friday, July 25th. Five analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $17.25.

Read Our Latest Analysis on Enovix

Enovix Stock Performance

ENVX opened at $9.64 on Thursday. Enovix has a 52-week low of $5.27 and a 52-week high of $16.49. The business’s fifty day moving average is $10.82 and its 200-day moving average is $10.18. The company has a debt-to-equity ratio of 0.82, a quick ratio of 4.11 and a current ratio of 4.37. The firm has a market cap of $1.90 billion, a P/E ratio of -12.20 and a beta of 2.09.

Enovix (NASDAQ:ENVXGet Free Report) last released its earnings results on Tuesday, September 9th. The company reported ($0.13) EPS for the quarter. Enovix had a negative net margin of 481.35% and a negative return on equity of 73.88%. The firm had revenue of $7.47 million during the quarter. Sell-side analysts expect that Enovix will post -1.01 EPS for the current fiscal year.

Insider Activity at Enovix

In related news, COO Ajay Marathe sold 120,000 shares of Enovix stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $12.01, for a total transaction of $1,441,200.00. Following the sale, the chief operating officer directly owned 1,027,259 shares in the company, valued at $12,337,380.59. The trade was a 10.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 14.10% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the stock. Cambridge Investment Research Advisors Inc. boosted its stake in Enovix by 15.5% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 67,088 shares of the company’s stock worth $492,000 after purchasing an additional 9,024 shares in the last quarter. Teacher Retirement System of Texas purchased a new stake in Enovix in the first quarter worth approximately $171,000. OneDigital Investment Advisors LLC raised its stake in Enovix by 16.5% during the 1st quarter. OneDigital Investment Advisors LLC now owns 35,253 shares of the company’s stock valued at $259,000 after buying an additional 5,003 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in Enovix by 0.5% in the first quarter. Bank of New York Mellon Corp now owns 504,179 shares of the company’s stock valued at $3,701,000 after acquiring an additional 2,640 shares during the period. Finally, Concurrent Investment Advisors LLC grew its position in Enovix by 4.9% during the first quarter. Concurrent Investment Advisors LLC now owns 66,604 shares of the company’s stock valued at $489,000 after buying an additional 3,123 shares during the period. Hedge funds and other institutional investors own 50.92% of the company’s stock.

Enovix Company Profile

(Get Free Report)

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Featured Stories

Analyst Recommendations for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.